Listas de seguimiento Ideas ProPicks IA Filtro Explorador de datos Gráficos Trabajo guardado

Knight Therapeutics Inc.

OTCPK:KHTRF

Canadá / Salud / Productos farmacéuticos

Visión general

Finanzas históricas a 5 años

Precio

4,17 USD


Key Metrics	Latest
Total Revenue	371,3 M
Adjusted EBITDA	55,957 M
EBITDA Margin	15,1%
Net Profit Margin	1,7%
Total Assets	963,8 M
Total Debt	49,459 M

5Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	12 Months	Dec-23	Dec-24

Revenue	199.52	243.48	293.56	328.20	371.30	371.30	328.20	371.30
% Growth		0.22	0.21	0.12	0.13			0.13

Adjusted EBITDA	2.97	32.46	40.98	53.26	55.96	55.96	53.26	55.96
% Margin	0.01	0.13	0.14	0.16	0.15	0.15	0.16	0.15

Adjusted EBIT	(26.31)	(12.83)	(17.06)	6.37	7.40	7.40	6.37	7.40
% Margin	(0.13)	(0.05)	(0.06)	0.02	0.02	0.02	0.02	0.02

Adjusted Net Income	30.78	15.36	(18.28)	2.09	6.23	6.23	2.09	6.23
% Margin	0.15	0.06	(0.06)	0.01	0.02	0.02	0.01	0.02

Adjusted Basic EPS	0.23	0.12	(0.16)	0.02	0.06	0.06	0.02	0.06

Cálculos de apoyo

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
						Original
CAD	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	Dec-24	Dec-23	Dec-24
	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM	YTD-1	YTD

Revenue	200	243	294	328	371	371	328	371
% Growth	NA	22.0%	20.6%	11.8%	13.1%			13.1%

Cost of Revenue	(118)	(128)	(156)	(176)	(197)	(197)	(176)	(197)
Gross Profit	82	115	138	153	174	174	153	174
% Revenue	40.9%	47.4%	47.0%	46.5%	47.0%	47.0%	46.5%	47.0%

Research and Development	(12)	(13)	(15)	(18)	(23)	(23)	(18)	(23)
Selling and Marketing	(36)	(39)	(48)	(46)	(54)	(54)	(46)	(54)
General and Admin	(35)	(35)	(40)	(37)	(45)	(45)	(37)	(45)
Other Inc / (Exp)	22	(25)	(83)	(73)	(51)	(51)	(73)	(51)
Total Operating Exp	(61)	(112)	(186)	(175)	(174)	(174)	(175)	(174)

Operating Income	21	3	(48)	(22)	1	1	(22)	1
% Revenue	10.6%	1.2%	-16.3%	-6.7%	0.2%	0.2%	-6.7%	0.2%

Interest Expense	11	4	4	0	1	1	0	1
Pre-tax Income	32	7	(44)	(22)	2	2	(22)	2
Earnings of Discontinued Ops.	0	0	0	0	0	0	0	0
Provision for Taxes	(0)	9	14	5	2	2	5	2
Net Income to Company	32	16	(30)	(17)	4	4	(17)	4
% Margin	15.9%	6.4%	-10.2%	-5.1%	1.2%	1.2%	-5.1%	1.2%

Minority Interest in Earnings	10	0	0	0	0	0	0	0
Net Income to Stockholders	42	16	(30)	(17)	4	4	(17)	4

Preferred Dividends	0	0	0	0	0	0	0	0
Other Adj.	0	0	0	0	0	0	0	0

Net Income to Common	42	16	(30)	(17)	4	4	(17)	4
% Margin	21.1%	6.4%	-10.2%	-5.1%	1.2%	1.2%	-5.1%	1.2%

As Reported
Basic EPS (Continuing Ops)	0.32	0.13	(0.26)	(0.16)	0.04	0.04	(0.16)	0.04
Diluted EPS (Continuing Ops)	0.32	0.13	(0.26)	(0.16)	0.04	0.04	(0.16)	0.04

WA Basic Shares Out.	131.78	124.48	114.89	107.47	101.04	101.04	107.47	101.04
WA Diluted Shares Out.	131.99	124.52	114.89	107.47	101.44	101.44	107.47	101.44

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	32	7	(44)	(22)	2	2	(22)	2
Addback: Net Interest Expense	(11)	(4)	(4)	(0)	(1)	(1)	(0)	(1)
Addback: Other Non Operating Expenses, Total	(46)	(15)	15	3	4	4	3	4
Addback: Depreciation & Amortization	29	45	58	47	49	49	47	49
Addback: Restructuring Charges	0	0	0	0	0	0	0	0
Addback: Merger / Acquisition Expenses	4	0	0	0	0	0	0	0
Addback: Goodwill Impairment	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Invest.	(4)	0	0	20	12	12	20	12
Addback: Gain (Loss) On Sale Of Assets	(3)	0	0	0	0	0	0	0
Addback: Asset Writedown	1	0	24	9	0	0	9	0
Addback: In Process R&D Expenses	0	0	0	0	0	0	0	0
Addback: Insurance Settlements	0	0	0	0	0	0	0	0
Addback: Legal Settlements	0	0	0	0	0	0	0	0
Addback: Other Unusual Items	1	(0)	(8)	(3)	(9)	(9)	(3)	(9)
Adjusted EBITDA	3	32	41	53	56	56	53	56
% Margin	1.5%	13.3%	14.0%	16.2%	15.1%	15.1%	16.2%	15.1%

Adjusted EBIT	(26)	(13)	(17)	6	7	7	6	7
% Margin	-13.2%	-5.3%	-5.8%	1.9%	2.0%	2.0%	1.9%	2.0%

Adjusted Net Income Reconciliation
Net Income to Company	32	16	(30)	(17)	4	4	(17)	4
Addback: Unusual Items	(1)	(0)	16	26	3	3	26	3
Less: Tax Benefit of Unusual Items (26%)	0	0	(4)	(7)	(1)	(1)	(7)	(1)
Adjusted Net Income	31	15	(18)	2	6	6	2	6
% Margin	15.4%	6.3%	-6.2%	0.6%	1.7%	1.7%	0.6%	1.7%

Error de carga

Knight Therapeutics Inc.

OTCPK:KHTRF

Canadá / Salud / Productos farmacéuticos

Finanzas históricas a 5 años